|
|
|
Data as a Public Good for the Public Good to Solve Immediate Real-World Challenges
4:00 PM - 5:30 PM
Institute for Precision Health Distinguished Lecture Series
The Beach at UCI Beall Applied Innovation
Register here
| | | |
|
|
UCI Spacial Omics Symposium
1:00 PM - 5:30 PM
Host: Genomics Research and Technology Hub and Institute for Precision Health
Gross Hall, 4th Floor Thorp Conference Center
Register by April 15 (space is limited)
| | | |
|
|
Precision Perioperative Therapy for Patients with Resectable NSCLC
UC Lung Cancer Consortium Investigators Meeting & Journal Club
5:30 PM - 6:30 PM
Virtual Meeting
Register for Zoom link
| | | |
|
|
Research in Progress Seminar with Anand Ganesan, MD, PhD
A New Approach to Target the Vascular Microenvironment in Tumors
12:00 PM - 1:00 PM
Virtual Seminar
Register for Zoom link
| | | |
|
|
Translational Science at UCI Chao Family Comprehensive Cancer Center: Opportunities for Collaboration and Clinical Trials
Speaker: Farshid Dayyani, MD, PhD
10:00 AM - 11:00 AM
Host: Genomics Research and Technology Hub (GRT Hub)
The Cove at UCI Applied Innovation
Join Zoom
| | | |
|
|
2024 UCI Campus-Wide Symposium on Basic Cancer Research
10:00 AM - 3:30 PM
Host: UCI Cancer Research Institute
The Cove at UCI
Register here
| | | |
|
|
Save the Date: Molecular Tumor Board Virtual Meeting
8:00 AM - 9:00 AM
Virtual Meeting
Learn more
| | | |
|
|
NIH Diversity-Focused Funding Opportunities
11:00 AM - 1:00 PM
Host: UC Cancer Consortium
Virtual Webinar
Register for Zoom link
| | | |
|
|
UCI Anti-Cancer Challenge Kickoff
4:30 PM - 6:00 PM
UCI Research Park - UA Event Space
Register here
| | |
Belonging, Equity and Empowerment (BEE) Scene | |
The CFCCC is accepting nominations for recognitions during different commemorative months to celebrate the backgrounds, experiences, and achievements of our members. Our upcoming Beyond Cancer Speaker Series in May will honor individuals from the Asian American and Pacific Islander (AAPI) community. Nominate a colleague by April 22 for this virtual speaking event. Questions? Contact Kimberly Castellanos at kecastel@hs.uci.edu.
| | |
|
Beyond Cancer Spotlight: Michelle Burroughs
Discover the journey of Michelle Burroughs, founding member of the CFCCC Community Equity Board (CEB). Through witnessing her family's struggles with navigating the healthcare system, Michelle found her calling to champion cancer and health equity, especially within African American, Black, and Caribbean (ABC) communities. Dive into her story to learn more about her passions, including her love for travel and live theatre.
| |
|
Accepting Nominations! Learning about each other cultivates an inclusive environment where everyone feels empowered to contribute and succeed. Nominate a colleague for a spotlight showcasing their unique stories beyond their roles at the CFCCC. Faculty, staff, and self-nominations are encouraged.
| |
|
Please Complete the Annual Core Facilities/Shared Resources User Survey
The School of Medicine and the CFCCC have partnered to survey users of SOM/CFCCC core research facilities regarding their satisfaction of services received and suggestions for improvement/future development. Please complete the survey only if you used any of the School of Medicine/CFCCC Core Research Facilities in 2023 (January 1, 2023 – December 31, 2023).
This survey is anonymous and your participation is voluntary, but highly encouraged to help us optimize our SOM/CFCCC research support structure. Thank you in advance for completing this survey by May 10!
| |
|
Join the CFCCC Leadership Team as Deputy Associate Director for Cancer Health Disparities & Community Engagement
The CFCCC is seeking a faculty member who is interested in cancer health disparities and community engagement in research, to enhance their leadership skills through hands-on experience and mentorship. Learn more and submit nomination.
Peer-Nominations Due: May 1
Self-Nominations Due: May 8
| |
|
The NIH All of Us Research Program Selects Publication by CFCCC Researchers for Research Highlights series
Congrats to co-authors Ivann Agapito, Ding Quan Ng, Joel Milam (CC), Arygrios Ziogas (CC), Hoda Anton-Culver (CC), Alexandre Chan (CC)!
The All of Us Science Communications team selected the publication, “Neuropsychiatric
complications and associated management in adolescent and young adult cancer survivors: An All of Us study,” published November 2023 in Cancer Medicine because of its public health impact and demonstrable use of All of Us participant data to drive health discoveries.
The Research Highlight is a plain-language summary of their study available in English and Spanish:
-
Learning About the Health of Young Cancer Survivors With All of Us
-
Aprendiendo con All of Us sobre la salud de los sobrevivientes jóvenes de cáncer
| |
|
Call for Cancer Research Proposals
The UCI Cancer Research Institute is pleased to announce that funds are available through the American Cancer Society Institutional Research Grant. This institutional grant will fund several proposals for one year at a level up to $60,000 per award. All eligible faculty from each school at the University of California, Irvine are encouraged to apply, so long as the proposal has a clear link to some aspect of cancer research. The purpose of the seed grants is to provide pilot funds for research in both basic and clinical cancer-related problems. Learn more about eligibility and application instructions.
Applications: April 30, 2024
| |
|
Administrative Supplements from NCI Division of Cancer Control and Population Sciences
Notice of Special Interest (NOSI) NOT-CA-24-032: Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations. Learn More.
- Applications: April 29, 2024
Notice of Special Interest (NOSI) NOT-CA-24-035: Administrative supplements for Assessing and Enhancing Survivorship Care. Learn More.
- Applications: June 4, 2024
If you're interested in applying to any of the above supplements, please email cfcccadmin@hs.uci.edu by Friday, April 19 with a 1-page research summary and your Biosketch. The CFCCC can only submit one application through the P30.
| |
|
Experimental Tissue Shared Resource (ETR) Offers Custom Tissue Microarray and Brightfield Whole Slides Scanning
The ETR is excited to discuss your project’s study design and tissue needs. We can now create custom tissue microarrays (TMA) with tissue you provide or human tissue remnants and scan whole histology slides at 40X. Selection of optimal representative tissue regions can be performed by our pathologist.
We can provide histology support for special transcriptomics platforms supported by GTH Share Resource
Questions? Contact Delia Tifrea, ETR Core Manager, 714-872-1093.
| |
|
The Biobehavioral Shared Resource (BBSR) Consultation & Comprehensive Project Request is Live
The BBSR is excited to discuss your project’s study design and needs, as well as see how our new menu of services can best support your project goals.
During our “Consultation Meeting” we’ll learn more about your project and how the BBSR can support your team. Ready to schedule? Complete the "Consultation Request" on iLab.
Questions? Contact Jose Lechuga, BBSR Core Manager.
| |
|
Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Available
Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs.
With Wen-pin Chen, MS, Senior Statistician & Manager for BSR:
With Thomas H. Taylor, PhD, Principal Statistician for BSR:
-
Every Wednesday from 2:00 - 3:00 PM via Zoom | No pre-booking necessary, drop in here
| |
|
For a curated list of internal, federal and foundation funding opportunities, please refer to CFCCC's Funding Opportunities webpage. Highlighted funding opportunities are listed below.
UCI & UC FUNDING OPPORTUNITIES
UCI CFCCC: A1 Bridge
Up to $20k in bridge funding to investigators who have received scores on NIH grant applications (i.e., not triaged) that have missed the funding pay line and will be resubmitted.
Applications: Due on a rolling basis
Learn More and Apply >>
| |
|
FOUNDATION FUNDING OPPORTUNITIES
2025 Pew-Stewart Scholars Program for Cancer Research
Focus Area: Assistant professors; basic or translational cancer research
$300k / 4 years
One candidate will be nominated
Internal Application: April 29, 2024
Learn More and Apply >>
(NEW!) 2024 V Foundation for Pediatric Cancer Research: V Scholar or Translational
Focus Area: Pediatric cancer research (exclusions: epidemiology, behavioral science, and health services research)
V Scholar: $600k / 3 years
Translational: $800k / 4 years
One candidate will be nominated
Internal Application: April 26, 2024
Learn More and Apply >>
The Hope Foundation for Cancer Research
Multiple awards available: research support, career development and community support
Applications: various deadlines, see below link
Learn More and Apply >>
| |
|
OTHER NON-FEDERAL FUNDING OPPORTUNITIES
Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians
$120k / year salary supported for 2 years
Applications: May 13, 2024
Learn More and Apply >>
| | |
|
|
Researchers build first reference map for harmful DNA
A team led by Wei Li (above left, with co-corresponding authors Ya Cui, Wenbin Ye and Jason Sheng Li) has built the first genetic reference maps for short lengths of DNA that are repeated multiple times and are known to cause more than 50 lethal human diseases, including amyotrophic lateral sclerosis (Lou Gehrig’s disease), Huntington’s disease and multiple cancers.
Read More >>
| | |
|
|
Dr. Shawn Griffin Received Volunteer Award from Hematology/Oncology Pharmacy Association (HOPA)
The Volunteer Award is given by HOPA to their members who dedicate volunteer service to the organization by participating in a committee or task force or serving as a representative of the group. Dr. Griffin is chair of the HOPA Practice Outcomes and Professional Benchmarking Committee.
Read More >>
| | |
|
|
Dr. Alexandre Chan Given Basic and Clinical Research Literature Award from Hematology/Oncology Pharmacy Association (HOPA)
He was recognized for the research that was presented in the article “Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort.” The research was a collaborative study with Dr. Joel Milam of the Program in Public Health and student pharmacist Ding Quan (Quinton) Ng, as well as Anamara Ritt-Olson, David R. Freyer, Kimberly A. Miller, and Stefanie M. Thomas.
Read More >>
| | | | |
